Details for New Drug Application (NDA): 062233
✉ Email this page to a colleague
NDA 062233 describes CLOXAPEN, which is a drug marketed by Glaxosmithkline and is included in two NDAs. Additional details are available on the CLOXAPEN profile page.
The generic ingredient in CLOXAPEN is cloxacillin sodium. There is one drug master file entry for this compound. Additional details are available on the cloxacillin sodium profile page.
The generic ingredient in CLOXAPEN is cloxacillin sodium. There is one drug master file entry for this compound. Additional details are available on the cloxacillin sodium profile page.
Summary for 062233
| Tradename: | CLOXAPEN |
| Applicant: | Glaxosmithkline |
| Ingredient: | cloxacillin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062233
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 250MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 500MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
